Skip to main content

Advertisement

Log in

Significance of adenylate cyclase system of the liver in its chronic diseases

  • Experimental Methods for Clinical Practice
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The activity of adenylate cyclase in the hepatocyte plasma membranes, content of cAMP, and cAMP/cGMP ratio in the liver and blood plasma are decreased in patients with chronic liver diseases (fatty dystrophy, chronic hepatitis, and cirrhosis). This decrease depends on the disease severity and is most pronounced in cirrhosis. The sensitivity of liver adenylate cyclase to insulin and glucagon is changed. It is concluded that disorders in the adenylate cyclase system are an important molecular mechanism in the pathogenesis of chronic liver diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. R. A. Vysotskaya,Prostaglandins and Gastrointestinal Hormones in Chronic Diseases of the Liver [in Russian], Author's Synopsis of Doct. Biol. Sci. Dissertation, Moscow (1992).

  2. A. S. Loginov and R. A. Vysotskaya,Vestn. Rossiisk. Akad. Med. Nauk, No. 12, 32–38 (1995).

    Google Scholar 

  3. M. V. Nesterova, E. S. Severin, A. A. Kondrashin, and T. T. Berezov,- No. 1, 46–59 (1992).

    Google Scholar 

  4. V. A. Tkachuk and P. V. Avdonin,Biokhimiya, No. 2, 333–336 (1981).

    Google Scholar 

  5. T. D. Cherkasova, V. A. Yurkiv, and V. I. Pokrovskii,Byull. Eksp. Biol. Med.,117, No. 3, 278–280 (1994).

    Article  CAS  Google Scholar 

  6. B. Bouscarel, S. Ceryak, and T. Cettys,Am. J. Physiol.,268, No. 6, 31–36, (1995).

    Google Scholar 

  7. D. Cooper, N. Mons, and J. Karpen,Nature,374, 421–424 (1995).

    Article  CAS  PubMed  Google Scholar 

  8. C. Cortinovis, F. Klimek, and E. Nogneira,Hepatology,18, No. 1, 160–164 (1993).

    Article  CAS  PubMed  Google Scholar 

  9. A. Diehl, S. Yang, P. Cote, and G. Wand,-,16, 1212–1219, (1992).

    Article  CAS  PubMed  Google Scholar 

  10. R. Duan and C. Erlanson-Albertsson,Scand. J. Gastroenterol.,27, No. 8, 644–648 (1992).

    CAS  PubMed  Google Scholar 

  11. L. Lukouras, M. Markianos, and G. Moussas,Drug Alcohol Depend.,21, No. 1, 7–9) 1088).

    Google Scholar 

  12. K. Miyamoto and S. French,Hepatology,8, No. 1, 53–60 (1988).

    CAS  PubMed  Google Scholar 

  13. L. Nagy,Biochem. J.,304, Pt. 1, 205–210 (1994).

    CAS  PubMed  Google Scholar 

  14. M. Saito,J. Pharmacolbiodyn.,15, No. 5, 449–454 (1992).

    CAS  Google Scholar 

  15. E. Sutherland, B. Dixon, H. Lefert,et al., Proc. Natl. Acad. Sci. USA,85, No. 22, 8673–8677 (1988).

    Article  CAS  PubMed  Google Scholar 

  16. K. Wong and R. Kisilevsky,Exp. Mol. Pathol.,40, No. 1, 122–134 (1984).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Medistiny, Vol. 124, No. 4, pp. 450–453, April 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vysotskaya, R.A., Loginov, A.S., Varvanina, G.G. et al. Significance of adenylate cyclase system of the liver in its chronic diseases. Bull Exp Biol Med 125, 399–401 (1998). https://doi.org/10.1007/BF02499170

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02499170

Key Words

Navigation